The E.mbrace study is a randomized, double-blind, placebo-controlled, multicenter, interventional phase 3 study evaluating the efficacy, safety, and immunogenicity of a single dose of the vaccine ...
Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase ...
Martin Friedlander, MD, PhD, discusses phase 3 macular telangiectasia findings, highlighting the potential for a decade-long ...
Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...
15h
Hosted on MSNARWR: Multiple Catalysts Ahead in 2025…ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Plozasiran Update On January 17, 2025, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced that the U.S. Food and Drug Administration (FDA) ...
In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...
New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.
Here’s a look at what the Trump administration’s decision to cut overhead funding for biomedical research means for ...
Clinical trials can assist you in getting the right treatment for your condition. Before you consider it, here's what you should know.
We recently compiled a list of the 10 Best Long Term ASX Stocks to Buy Now. In this article, we are going to take a look at ...
Cybin pushes forward with Phase 3 depression trials after posting a narrower loss, while securing a $100M funding program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results